Antivirals For COVID
Richard Marsden, CEO of Synairgen plc discusses full results from its SGO16 Phase II trial of its inhaled interferon beta formulation (SNG001) for the t...
270 articles
Richard Marsden, CEO of Synairgen plc discusses full results from its SGO16 Phase II trial of its inhaled interferon beta formulation (SNG001) for the t...
Noam Emanuel, Co-Founder and CSO of PolyPid, a late-stage biopharma company aiming to improve surgical outcomes, discusses the second most prevalent typ...
Jeffrey Stark, MD, Head of Medical Immunology at UCB discusses the results from the BE RADIANT and BE SURE studies, comparing the efficacy and safety of...
Opioid use and dependency increased during the pandemic. Learn more on Health Professional Radio.
Scott Schliebner, SVP and Head of the Center for Rare Diseases at PRA Health Sciences, a global healthcare intelligence partner, discusses the launch of...
announced (March 2021) that the first patient has been dosed in the Phase 1 multi-center clinical trial for CT-0508, studying the potential of chimeric ...
Stephen Brannan, Chief Medical Officer at Karuna Therapeutics discusses positive data recently published in the New England Journal of Medicine from the...
Jamie Milas, Vice President of Marketing at Medical Microinstruments S.p.A. Learn more on Health Professional Radio.
Lamont, President and Chief Operating Officer at Inteliquet™, a leader in clinical trial matching, discusses the impact COVID has had on clinical tria...
Samuel Lederman, obstetrician, gynecologist, and a founding member of Palm Beach Obstetrics & Gynecology, discusses the positive 12-week primary analysi...